CNS Safety Screening Under ICH S7A Guidelines Requires Observations of Multiple Behavioral Units to Assess Motor...

Area of Science:

• Neuroscience
• Pharmacology
• Behavioral Science

Background:

• Federal agencies increasingly emphasize behavioral analysis for safety pharmacology and neurotoxicity screening.
• Central nervous system (CNS) safety assessment relies on understanding diverse behavioral units.
• A singular approach is insufficient for a complete understanding of motor control neural pathways.

Purpose of the Study:

• To highlight the importance of comprehensive behavioral analysis in CNS safety testing.
• To underscore the necessity of adhering to regulatory guidelines for predictive validity.
• To caution against cost-cutting measures that compromise the integrity of safety assays.

Main Methods:

• Adherence to International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use S7A protocols.
• Inclusion of functional observation batteries assessing home cage activity, handling response, and open-field behavior.
• Quantitative measurement of 3-dimensional activity using automated photobeam arenas.

Main Results:

• Current CNS safety assessments require detailed behavioral analysis.
• Functional observation batteries and automated arenas provide comprehensive data.
• Regulatory guidelines mandate Good Laboratory Practices for these assays.

Conclusions:

• Comprehensive behavioral analysis is essential for accurate CNS safety assessment.
• Compromising the "reduce use" principle or cost-cutting jeopardizes assay validity.
• Maintaining the integrity of tier I safety testing is critical for drug safety.